BACKGROUND Delayed hemolytic transfusion reaction (DHTR) with hyperhemolysis is a
potentially fatal complication resulting from alloimmunization that can cause severe …

BACKGROUND Delayed hemolytic transfusion reactions (DHTRs) are serious complications
of RBC transfusion that can occur in previously alloimmunized patients. Patients who require …

BACKGROUND Hyperhemolysis in sickle cell disease is a rare and potentially life‐
threatening complication of transfusion. STUDY DESIGN AND METHODS In this article we …

Delayed hemolytic transfusion reaction (DHTR), a life-threatening transfusion complication
in sickle cell disease (SCD), is characterized by a marked hemoglobin drop with destruction …

BACKGROUND Patients with sickle cell disease (SCD) often require red blood cell (RBC)
transfusions but alloimmunization remains a significant complication. Alloantibodies can …

Background Delayed haemolytic transfusion reaction (DHTR) is mainly caused by an
immune response to transfused red blood cells (RBC s). Immunized patients have a high …

Red blood cell (RBC) transfusion therapy is a key component in the comprehensive
management of patients with sickle cell disease (SCD). Consequently, most adult SCD …

Delayed hemolytic transfusion reaction (DHTR) is a life-threatening complication in patients
with sickle cell disease, characterized by difficulties in diagnosis and management. Certain …

Delayed hemolytic transfusion reaction (DHTR) is an unpredictable severe complication of
transfusion in patients with sickle cell disease (SCD). It presents clinically as a vaso …

Patients with sickle cell disease (SCD) often receive red blood cell (RBC) transfusion
support for the prevention and management of many acute and chronic disease …